Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07038124 in Atopic Dermatitis and Plaque Psoriasis
NCT04664153Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of PF-07038124 in atopic dermatitis (AD), plaque psoriasis, sponsored by Pfizer. Started Dec 2020; status: completed.
02
Drugs
PF-07038124
03
Conditions
atopic dermatitis (AD)plaque psoriasis
Beyond the preview
Go deeper on NCT04664153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664153.